Product Offerings
Products:
Poultry Vaccines: XINZHILIUXIAN, XINLIUXIAN, Meilanqing, Meilanke
Duck Vaccines: Meilanxiaoya, Meilanyakang
Swine Vaccines: Porcine Parvovirus Vaccine, Porcine Reproductive and Respiratory Syndrome Vaccine
Established in Shangqiu, China, Shangqiu Meilan Biological Engineering Co., Ltd. is a comprehensive animal health company specializing in the development, production, and distribution of veterinary vaccines and biological products. With a strong R&D foundation and a clear focus on disease prevention in poultry, swine, and ducks, the company is positioned as a prominent player in China’s veterinary pharmaceuticals sector and is expanding its footprint in international markets.
Core Business
The core operations of Meilan Biological Engineering revolve around:
- Veterinary Vaccines
- Animal Health Pharmaceuticals
- Feed Additives and Biologicals
Their primary focus is the prevention and control of infectious diseases affecting poultry and livestock, thereby improving animal health and farm productivity.
Product & Service Offerings
The company’s product portfolio spans a wide range of inactivated and live vaccines, formulated to meet both domestic and international veterinary standards.
Poultry Vaccines
- XINZHILIUXIAN – A new-generation live vaccine for Newcastle Disease and Avian Influenza
- XINLIUXIAN – Bivalent vaccine for Avian Influenza H5 and H9 strains
- Meilanqing – Designed for comprehensive immunity in broilers and layers
- Meilanke – Combination vaccine for Newcastle Disease and Infectious Bronchitis
Duck Vaccines
- Meilanxiaoya – Effective against Duck Viral Enteritis and Duck Hepatitis
- Meilanyakang – Immunization solution for Duck Reovirus and Parvovirus
Swine Vaccines
- Porcine Parvovirus Vaccine – Inactivated vaccine for reproductive diseases
- Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine – Key solution for PRRS virus control
These products are tailored for mass immunization programs and offer robust protection in high-density farming environments.
Specialization and Unique Selling Proposition (USP)
Shangqiu Meilan’s unique advantage lies in its integrated production system which includes:
- Self-owned GMP-certified manufacturing facilities
- In-house R&D laboratories
- Veterinary testing centers
- Cold-chain logistics and field technical support
The company’s emphasis on multi-strain, combination vaccines allows it to deliver cost-effective and wide-spectrum disease coverage to its clients.
Financials and Business Growth
Though exact revenue figures are not publicly available, Meilan Biological’s expansion across China and into regions like Southeast Asia, the Middle East, and parts of Africa suggests a healthy and growing financial base. The company:
- Supplies to over 5,000 commercial farms domestically
- Reports an annual production capacity of over 1 billion doses
- Maintains long-term supply agreements with provincial veterinary stations and integrators
Shipment Records
Based on international trade data:
- Meilan Biological has made consistent exports to Vietnam, Myanmar, Bangladesh, Egypt, and Nigeria
- Export records over the last 3 years indicate over 85 documented international shipments
- Main export products include poultry vaccines and swine biologicals
Target Market
The company's key markets include:
- Large-scale poultry and swine integrators
- Animal health agencies and veterinary distributors
- International NGOs involved in livestock disease control
- Private and government livestock enterprises
Meilan targets both developing and established veterinary markets that require reliable immunization solutions at competitive pricing.
Capabilities
- GMP-compliant production zones for vaccines and injectables
- Advanced QC and QA systems with real-time batch tracking
- Veterinary field support teams across major provinces in China
- Cross-border export experience with multilingual regulatory teams
Certifications and Compliance
- GMP Certification from China’s Ministry of Agriculture
- Compliance with Veterinary Biological Product Registration standards
- Products developed according to OIE guidelines for key animal diseases
- Ongoing efforts for international registration and WHO PQ pathways
Customer Testimonials
“We have used Meilan's poultry vaccines for over four years. The results in mortality reduction and weight gain have exceeded expectations.”
— Chief Veterinarian, Hebei Zhongyuan Livestock Co., Ltd.
“Their multi-strain vaccine platform makes immunization much easier for large farms. The after-sales support is professional and responsive.”
— Technical Director, Yangon Poultry Farms, Myanmar
Major Achievements
- Recognized as a High-Tech Enterprise of Henan Province
- Key contributor to China’s National Animal Disease Prevention Program
- Developed 7 proprietary strains for vaccine formulations
- Leading participant in livestock disease surveillance programs
Shangqiu Meilan Biological Engineering Co., Ltd. continues to strengthen its position as a trusted provider of comprehensive animal disease solutions, backed by scientific research, international compliance, and a commitment to improving animal health and agricultural productivity worldwide.